Search

Abraham A Grossman

from Englewood, NJ
Age ~67
Get Report
Also known as:
Abraham R Grossman, Avi Faye Grossman, Avi R Grossman, Avi Grossman Auraham, Avraham Grossman, Abraham G Rossman, Abi Grossman, Auraham Avi Grossman, Allen Grossman, Abraham Grussman
Phone and address:
400 Douglas St, Englewood, NJ 07631
(201) 503-1569
Related to:
Rebecca L Leshkowitz, 48Eli Leshkowitz, 41Rachel Leshkowitz, 38Naftali Leshkowitz, 53Eli Leshkowitz
Connected to:
Aline S Grossman, 55Andrea K Grossmann, 49Anna K Grossman, 43Atina J Grossmann, 73Beatrice B Grossman, 96Briar F Grossman, 64Caroline R Grossmann, 57Carolyn A Grossman, 62Chloe Grossman, 47Christina L Grossman, 54

Abraham Grossman Phones & Addresses

  • 400 Douglas St, Englewood, NJ 07631 (201) 503-1569
  • 324 Oakwood Rd, Englewood, NJ 07631
  • 435 Lyncrest Rd, Englewood, NJ 07631
  • Teaneck, NJ
  • Cambridge, MA
  • New York, NY
  • Berlin, NJ
  • 324 Oakwood Rd, Englewood, NJ 07631 (201) 888-5801

Work

Position: Food Preparation and Serving Related Occupations

Professional Records

License Records

Abraham C Grossman

License #:
229 - Expired
Category:
Nursing Home Administrator
Issued Date:
Jan 1, 1971

Business Records

Name / Title
Company / Classification
Phones & Addresses
Abraham C. Grossman
Partner
Lyden Nursing Home
Skilled Nursing Care Facility
2737 27 St, Long Island City, NY 11102
(718) 932-4613
Abraham Grossman
Owner
Westchester Economy Landscaping
Whol Farm/Garden Machinery
666 Washington Ave, Pleasantville, NY 10570
Abraham Grossman
Principal
Healthcare Consulting LLC
Business Consulting Services
372 Audubon Rd, Englewood, NJ 07631
Abraham Grossman
Founder, President
Q-RNA, INC
Noncommercial Research Organization Medical Laboratory
3960 Broadway STE 407, New York, NY 10032
(212) 568-0365
Abraham C. Grossman
Chairman
CHANA & DEVORAH REALTY, INC
Real Estate Agent/Manager
1569-49 St, Brooklyn, NY 11219
1569 49 St, Brooklyn, NY 11219
Abraham Grossman
Mnesis Company LLC
Commercial Physical Research
666 Washington Ave, Pleasantville, NY 10570

Publications

Us Patents

Compositions And Methods For Binding Agglomeration Proteins

View page
US Patent:
7232807, Jun 19, 2007
Filed:
Apr 22, 2005
Appl. No.:
11/112953
Inventors:
Abraham Grossman - Pleasantville NY, US
Valentine M. Kryukov - Puschino, RU
Brian Neil Zeiler - Washington Township NJ, US
Assignee:
Oligomerix, Inc. - New York NY
International Classification:
C07H 21/02
C07H 21/00
A61K 31/70
C12N 15/11
US Classification:
514 44, 536 256, 536 231, 977704
Abstract:
Amplibody compositions and methods used to interact with agglomeration proteins are disclosed herein. Compositions herein comprise one or more DNA or RNA molecules having affinity for at least one agglomeration protein. The nucleic acid component is a naturally or non-naturally occuring molecule with twenty or more ribonucleotide bases. For RNA, at least one nucleotide sequence portion of this RNA molecule has affinity to at least one consensus sequence present in the agglomeration RNA-binding protein. The portion of nucleotide sequence of RNA having affinity for agglomeration proteins is a sequence that is derived from either and RNA virus, and RNA agglomeration proteins is a sequence that is derived from either and RNA virus, an RNA phage, a messenger RNA (“mRNA”), a ribosomal RNA (“rRNA), a transfer RNA (“tRNA”), a sequence that is received as a template by one or more RNA dependent RNA polymerases, or a combination thereof. Methods disclosed herein are directed towards detecting the presence of one or more agglomeration proteins in a sample matrix using the amplibody compositions described herein.

Methods, Compositions And Apparatus For Making Nucleic Acid Molecules Having A Selected Affinity To A Target Molecule

View page
US Patent:
20030087233, May 8, 2003
Filed:
Dec 29, 2000
Appl. No.:
09/752231
Inventors:
Abraham Grossman - Pleasantville NY, US
Assignee:
Q-RNA, Inc.
International Classification:
C12Q001/68
C12P019/34
C12M001/34
US Classification:
435/006000, 435/091200, 435/287200
Abstract:
The present invention is directed to methods, compositions, kits and devices for making a nucleic acid having selected affinity to a target molecule. One embodiment of the present invention is a method of making a replicatable nucleic acid template having a selected affinity to a target. The method comprises the step of applying a selection to a first generation comprising at least one replicatable nucleic acid template as the replicatable nucleic acid template is replicated by a nucleic acid polymerase to form at least one subsequent generation comprising a replicatable nucleic acid template. The selection is based on the affinity of the replicatable nucleic template of different generations to the target. The nucleic acid polymerase introduces genetic variability between generations of the replicatable nucleic acid template to produce replicatable nucleic acid templates having different affinities to the target. The replicatable nucleic acid templates are separated on the basis of the affinity of the replicatable nucleic acid template to the target.

Compositions And Methods For Binding Agglomeration Proteins

View page
US Patent:
20040005543, Jan 8, 2004
Filed:
Jun 26, 2003
Appl. No.:
10/343694
Inventors:
Abraham Grossman - New York NY, US
Valentine Kryukov - New York NY, US
Brian Zeiler - Twp. of Washington NJ, US
International Classification:
C12Q001/70
C12Q001/68
C07H021/04
C12N007/00
C12N015/86
US Classification:
435/005000, 435/006000, 435/456000, 435/235100, 536/023720
Abstract:
Amplibody compositions and methods used to interact with agglomeration proteins are disclosed herein. Compositions herein comprise one or more DNA or RNA molecules having affinity for at least one agglomeration protein. The nucleic acid component is a naturally or non-naturally occuring molecule with twenty or more ribonucleotide bases. For RNA, at least one nucleotide sequence portion of this RNA molecule has affinity to at least one consensus sequence present in the agglomeration RNA-binding protein. The portion of nucleotide sequence of RNA having affinity for agglomeration proteins is a sequence that is derived from either and RNA virus, and RNA agglomeration proteins is a sequence that is derived from either and RNA virus, an RNA phage, a messenger RNA (“mRNA”), a ribosomal RNA (“rRNA”), a transfer RNA (“tRNA”), a sequence that is received as a template by one or more RNA dependent RNA polymerases, or a combination thereof. Methods disclosed herein are directed towards detecting the presence of one or more agglomeration proteins in a sample matrix using the amplibody compositions described herein.

Methods Of Detection Employing Immuno-Q-Amp Technology

View page
US Patent:
20050214805, Sep 29, 2005
Filed:
Nov 9, 2004
Appl. No.:
10/985183
Inventors:
Abraham Grossman - New York NY, US
Assignee:
Q-RNA, Inc. - New York NY
International Classification:
C12Q001/68
G01N033/53
G01N033/567
US Classification:
435006000, 435007200
Abstract:
Disclosed herein are methods of detecting target molecules from a complex sample using a modified affinity ligand. In particular, the modified affinity ligand is an antibody specific for the target and has conjugated to it a nucleic acid molecule. This conjugated nucleic acid molecule serves as a template for a replicase that can replicate the template a billion-fold in an matter of minutes. The replication products then serve to facilitate a detectable signal indicating the presence of the target in the sample.

Compositions And Methods For Binding Agglomeration Proteins

View page
US Patent:
20050266401, Dec 1, 2005
Filed:
Apr 22, 2005
Appl. No.:
11/112929
Inventors:
Abraham Grossman - Pleasantville NY, US
Valentine Kryukov - Puschino, RU
Brian Zeiler - Washington Township NJ, US
Assignee:
Q-RNA - New York NY
International Classification:
C12Q001/70
C12Q001/68
US Classification:
435005000, 435006000
Abstract:
Amplibody compositions and methods used to interact with agglomeration proteins are disclosed herein. Compositions herein comprise one or more DNA or RNA molecules having affinity for at least one agglomeration protein. The nucleic acid component is a naturally or non-naturally occuring molecule with twenty or more ribonucleotide bases. For RNA, at least one nucleotide sequence portion of this RNA molecule has affinity to at least one consensus sequence present in the agglomeration RNA-binding protein. The portion of nucleotide sequence of RNA having affinity for agglomeration proteins is a sequence that is derived from either and RNA virus, and RNA agglomeration proteins is a sequence that is derived from either and RNA virus, an RNA phage, a messenger RNA (“mRNA”), a ribosomal RNA (“rRNA), a transfer RNA (“tRNA”), a sequence that is received as a template by one or more RNA dependent RNA polymerases, or a combination thereof. Methods disclosed herein are directed towards detecting the presence of one or more agglomeration proteins in a sample matrix using the amplibody compositions described herein.

Compositions And Methods For Binding Agglomeration Proteins

View page
US Patent:
20050266402, Dec 1, 2005
Filed:
Apr 22, 2005
Appl. No.:
11/112954
Inventors:
Abraham Grossman - Pleasantville NY, US
Valentine Kryukov - Puschino, RU
Brian Zeiler - Washington Township NJ, US
Assignee:
Q-RNA - New York NY
International Classification:
C12Q001/70
C12Q001/68
US Classification:
435005000, 435006000
Abstract:
Amplibody compositions and methods used to interact with agglomeration proteins are disclosed herein. Compositions herein comprise one or more DNA or RNA molecules having affinity for at least one agglomeration protein. The nucleic acid component is a naturally or non-naturally occuring molecule with twenty or more ribonucleotide bases. For RNA, at least one nucleotide sequence portion of this RNA molecule has affinity to at least one consensus sequence present in the agglomeration RNA-binding protein. The portion of nucleotide sequence of RNA having affinity for agglomeration proteins is a sequence that is derived from either and RNA virus, and RNA agglomeration proteins is a sequence that is derived from either and RNA virus, an RNA phage, a messenger RNA (“mRNA”), a ribosomal RNA (“rRNA”), a transfer RNA (“tRNA”), a sequence that is received as a template by one or more RNA dependent RNA polymerases, or a combination thereof. Methods disclosed herein are directed towards detecting the presence of one or more agglomeration proteins in a sample matrix using the amplibody compositions described herein.

Methods, Compositions And Apparatus For Making Nucleic Acid Molecules Having A Selected Affinity To A Target Molecule

View page
US Patent:
20050272081, Dec 8, 2005
Filed:
May 24, 2005
Appl. No.:
11/135673
Inventors:
Abraham Grossman - Pleasantville NY, US
Assignee:
Q-RNA, Inc. - New York NY
International Classification:
C12Q001/68
C12P019/34
US Classification:
435006000, 435091200
Abstract:
The present invention is directed to methods, compositions, kits and devices for making a nucleic acid having selected affinity to a target molecule. One embodiment of the present invention is a method of making a replicatable nucleic acid template having a selected affinity to a target. The method comprises the step of applying a selection to a first generation comprising at least one replicatable nucleic acid template as the replicatable nucleic acid template is replicated by a nucleic acid polymerase to form at least one subsequent generation comprising a replicatable nucleic acid template. The selection is based on the affinity of the replicatable nucleic template of different generations to the target. The nucleic acid polymerase introduces genetic variability between generations of the replicatable nucleic acid template to produce replicatable nucleic acid templates having different affinities to the target. The replicatable nucleic acid templates are separated on the basis of the affinity of the replicatable nucleic acid template to the target.

Methods Of Detection Employing Immuno-Q-Amp Technology

View page
US Patent:
20060024736, Feb 2, 2006
Filed:
Sep 28, 2005
Appl. No.:
11/237046
Inventors:
Abraham Grossman - Pleasantville NY, US
Assignee:
Q-RNA, Inc. - New York NY
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
Disclosed herein are methods of detecting target molecules from a complex sample using a modified affinity ligand. In particular, the modified affinity ligand is an antibody specific for the target and has conjugated to it a nucleic acid molecule. This conjugated nucleic acid molecule serves as a template for a replicase that can replicate the template a billion-fold in an matter of minutes. The replication products then serve to facilitate a detectable signal indicating the presence of the target in the sample.
Control profile
Abraham A Grossman from Englewood, NJ, age ~67 Get Report